Old Web
English
Sign In
Acemap
>
authorDetail
>
SS Lund
SS Lund
Boehringer Ingelheim
Empagliflozin
Medicine
EMPA
Internal medicine
Outcome (game theory)
2
Papers
0
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Empagliflozin reduces the total burden of cardiovascular events including recurrent events in the EMPA-REG OUTCOME trial
2021
Diabetologie Und Stoffwechsel
David Fitchett
Silvio E. Inzucchi
Bernard Zinman
C. Wanner
Sd. Anker
Stuart J. Pocock
Stefan Kaspers
Jyothis T. George
Oe Johansen
Waheed Jamal
Stefan Hantel
SS Lund
Show All
Source
Cite
Save
Citations (0)
Empagliflozin Reduces the Total Burden of All-cause Hospitalisations and All-cause Mortality in the EMPA-REG OUTCOME trial
2021
Diabetologie Und Stoffwechsel
Silvio E. Inzucchi
Bernard Zinman
C. Wanner
David Fitchett
Stefan D. Anker
Stuart J. Pocock
Stefan Kaspers
Jyothis T. George
Oe Johansen
Waheed Jamal
Stefan Hantel
SS Lund
Show All
Source
Cite
Save
Citations (0)
1